[Federal Register Volume 60, Number 101 (Thursday, May 25, 1995)]
[Notices]
[Page 27790]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-12785]



-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 22, 1995, Roche 
Diagnostic Systems Inc., 1080 U.S. Highway 202, Somerville, New Jersey 
08876, made application to the Drug Enforcement Administration (DEA) 
for registration as a bulk manufacturer of the basic classes of 
controlled substances listed below:

------------------------------------------------------------------------
                           Drug                               Schedule  
------------------------------------------------------------------------
Lysergic acid diethylamide (7315).........................  I           
Tetrahydrocannabinols (7370)..............................  I           
Phencyclidine (7471)......................................  II          
Methadone (9250)..........................................  II          
Morphine (9300)...........................................  II          
------------------------------------------------------------------------

    The firm plans to manufacture very small quantities of the listed 
controlled substances which will be incorporated in drug of abuse 
detection kits.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application and may also file a written 
request for a hearing thereon in accordance with 21 CFR 1301.54 and in 
the form prescribed by 21 CFR 1316.47.
    Any such comments, objections, or requests for a hearing may be 
addressed to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, United States Department of 
Justice, Washington, D.C. 20537, Attention: DEA Federal Register 
Representative (CCR), and must be filed no later than June 26, 1995.

    Dated May 18, 1995.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 95-12785 Filed 5-24-95; 8:45 am]
BILLING CODE 4410-09-M